Skip to content

Industrial Pharmacist

  • Home
  • Blog
  • Forums
  • Courses
  • Calculation
  • About Us
  • Privacy Policy
  • ANDA
  • ADL
  • FRD
  • QbD
  • QA
  • QC
  • RA
  • FDA
  • VS
  • SCM
  • Q&A
  • Dissolution
  • Data Integrity
  • Validation
  • Manufacturing
  • Packaging
  • Microbiology
Industrial Pharmacist
  • Root Cause Mastery | From Correction to Prevention
    QA

    Root Cause Mastery | From Correction to Prevention

    Byipharmacist December 16, 2025December 16, 2025

    ROOT CAUSE ANALYSIS, WHERE QUALITY GROWS UP A strong Root Cause Analysis converts confusion into cause–and–effect clarity: 1) It separates symptoms from sources2) It turns firefighting into learning3) It transforms compliance into confidence HUMAN ERROR ≠ ROOT CAUSE Human actions are effects of system design & not the source of failure. Ask deeper questions:1) Was…

    Read More Root Cause Mastery | From Correction to PreventionContinue

  • Materials are Used in Pharmaceutical Blister Packs
    Packaging

    Materials are Used in Pharmaceutical Blister Packs

    Byipharmacist December 16, 2025December 16, 2025

    Aluminum Foil: Aluminum foil offers the highest barrier overall, against both moisture and oxygen, completely blocking light and gases. Aluminum foil used for highly sensitive drugs due to its exceptional impermeability. Ethylene Vinyl Alcohol (EVOH): oxygen barrier properties, particularly in dry conditions,but is moisture sensitive and often used in multilayer films with hydrophobic outer layers…

    Read More Materials are Used in Pharmaceutical Blister PacksContinue

  • CAPA Effectiveness Metrics
    QA

    CAPA Effectiveness Metrics

    Byipharmacist December 16, 2025December 16, 2025

    To most organizations, CAPA metrics are about compliance i.e., meeting timelines, closing investigations, passing audits. To regulators, they are a window into your quality culture i.e., how we think, learn & respond to risk. ILLUSION OF 100% ON-TIME SUCCESS Many companies proudly report: 1) 98% CAPAs closed on time2) 100% effectiveness checks completed3) Zero overdue…

    Read More CAPA Effectiveness MetricsContinue

  • Scale Up and Exhibit Batches in Pharmaceutical Industry
    Manufacturing

    Scale Up and Exhibit Batches in Pharmaceutical Industry

    Byipharmacist November 21, 2025November 21, 2025

    Scaling up from the lab bench to commercial manufacturing is one of the most critical steps in pharmaceutical development. It is not just about making a bigger batch but it is about proving consistency, ensuring quality, and meeting regulatory expectations. Below a simple checklist that often guides scale-up and exhibit batch execution: Pre-Scale Up: finalize…

    Read More Scale Up and Exhibit Batches in Pharmaceutical IndustryContinue

  • Optimizing Surfactant Selection in Dissolution Studies
    Dissolution

    Optimizing Surfactant Selection in Dissolution Studies

    Byipharmacist November 14, 2025November 14, 2025

    Surfactants play a key role in improving solubility and maintaining sink conditions, but using too much can artificially speed up drug release. If you get similar dissolution results across different concentrations, it’s best to go with the lowest level that is still physiologically relevant. Reproducibility matters – choose a concentration that gives consistent results across…

    Read More Optimizing Surfactant Selection in Dissolution StudiesContinue

  • Frequently Asked Questions About the Apex (Peak) Vessel
    Dissolution | Uncategorized

    Frequently Asked Questions About the Apex (Peak) Vessel

    Byipharmacist November 14, 2025

    One of the areas of the most focus in the dissolution world right now is the Apex vessel, which was formerly called the Peak vessel. With all of this new attention, I thought it would be good to answer some of the most common customers I get from scientists about this unique vessel. When should…

    Read More Frequently Asked Questions About the Apex (Peak) VesselContinue

  • Strategic Use of FOI-Based Biopharmaceutical Reviews in Generic Drug Development
    ANDA

    Strategic Use of FOI-Based Biopharmaceutical Reviews in Generic Drug Development

    Byipharmacist October 2, 2025October 2, 2025

    In the development of generic pharmaceutical products, aligning formulation design and regulatory strategy with prior approved data significantly improves the chances of first-time-right submissions. One highly effective method to gain such insight is through the use of biopharmaceutical review documents obtained via FOI requests. These documents, available publicly through regulatory agencies such as the USFDA…

    Read More Strategic Use of FOI-Based Biopharmaceutical Reviews in Generic Drug DevelopmentContinue

  • Affinity Chromatography: A Powerful Tool for Biomolecule Separation
    Analytical Development

    Affinity Chromatography: A Powerful Tool for Biomolecule Separation

    Byipharmacist October 2, 2025October 2, 2025

    Affinity Chromatography is one of the most powerful and precise techniques for the analysis and separation of biomolecules such as proteins, enzymes, and antibodies. Due to its high specificity and ability to isolate specific compounds from complex mixtures, it is highly popular in pharmaceutical industries, biotechnology, and biological research. Principle of Affinity Chromatography In this…

    Read More Affinity Chromatography: A Powerful Tool for Biomolecule SeparationContinue

Page navigation

1 2 3 … 44 Next PageNext

Popular Articles

  • Difference Between ISO Standards and EU GMP Annex 1

    Difference Between ISO Standards and EU GMP Annex 1

  • Titration in Pharmaceutical Industry

    Titration in Pharmaceutical Industry

  • Calculation of Peak Purity in HPLC

    Calculation of Peak Purity in HPLC

  • Analytical Method Validation | Avoiding Common Pitfalls in CTD Submissions

    Analytical Method Validation | Avoiding Common Pitfalls in CTD Submissions

  • Ensuring Compliance with 21 CFR Part 11 in Pharmaceutical Industry

    Ensuring Compliance with 21 CFR Part 11 in Pharmaceutical Industry

  • Audits in the Pharmaceutical Industry | Internal vs External

    Audits in the Pharmaceutical Industry | Internal vs External

  • USFDA Complaint Laboratory KPIs Measurements

    USFDA Complaint Laboratory KPIs Measurements

  • Difference Between Generic ANDA and 505(b)(2) Submissions

    Difference Between Generic ANDA and 505(b)(2) Submissions

  • Difference Between Disinfection and Sterilization

    Difference Between Disinfection and Sterilization

  • Key Elements of an Analytical Worksheet

    Key Elements of an Analytical Worksheet

  • Interview Questions and Answers on GMP

    Interview Questions and Answers on GMP

  • Quality by Design (QbD) and Design Space in Pharmaceutical Development

    Quality by Design (QbD) and Design Space in Pharmaceutical Development

  • CPP and CQA in Different Stages of Drug Product Manufacturing

    CPP and CQA in Different Stages of Drug Product Manufacturing

  • FDA Recall Classification System

    FDA Recall Classification System

  • Analytical Test Method Validation and Verification

    Analytical Test Method Validation and Verification

  • GLP vs GMP vs GCP | Similarities and Differences

    GLP vs GMP vs GCP | Similarities and Differences

  • Pharmaceutical Validation Interview Questions and Answers

    Pharmaceutical Validation Interview Questions and Answers

  • Difference Between Purity and Potency

    Difference Between Purity and Potency

  • Difference Between RLD and RS

    Difference Between RLD and RS

  • USFDA Databases

    USFDA Databases

© 2025 Industrial Pharmacist

  • Privacy Policy
  • DMCA
  • Contact Us
Industrial Pharmacist
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
  • Home
  • Blog
  • Forums
  • Courses
  • Calculation
  • About Us
  • Privacy Policy